A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer are helped by a targeted cancer treatment that had been under development but was shelved.
Regeneron’s EYLEA HD injection received FDA approval
EYLEA HD is indicated for the treatment of wet age-related macular degeneration. Credit: Image Point Fr/Shutterstock.com. The US Food and Drug Administration (FDA) has granted